|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 15-05-06 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 15-04-29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +0.79% | -6.16% | -7.71% | +18.87% | +62.91% | +49.32% | +74.50% | +5.10% | - | 65.83B | |
| +1.92% | +10.35% | +14.55% | +10.62% | +16.21% | +13.02% | +87.74% | -14.94% | +237.66% | 51.87B | |
| +6.91% | +8.57% | -10.47% | +3.53% | +8.84% | +6.88% | +72.12% | +206.56% | +5,247.50% | 51.2B | |
| +0.74% | +2.75% | +0.54% | +31.36% | +18.83% | +26.31% | +45.29% | +6.49% | +259.92% | 43.76B | |
| +3.87% | +10.15% | +9.59% | +23.80% | +26.56% | +20.69% | +132.73% | +3.19% | +1,065.86% | 42.09B | |
| +7.91% | +4.30% | +2.93% | +8.96% | +146.77% | +263.91% | +602.72% | +629.86% | - | 39.04B | |
| -0.40% | +9.85% | +10.03% | +14.37% | +14.51% | +17.04% | +59.17% | +9.63% | +167.54% | 34B | |
| +3.84% | -2.34% | -0.60% | +30.82% | +59.19% | +39.18% | +8.57% | -57.11% | - | 25.2B | |
| +2.36% | +5.34% | +15.13% | +40.88% | +28.37% | +30.98% | +26.07% | -11.13% | +125.09% | 22.8B | |
| +2.20% | +2.43% | -5.09% | -1.07% | -4.23% | -15.54% | +0.29% | -66.16% | - | 22.41B | |
| +0.40% | -1.16% | -20.27% | -10.61% | -45.03% | -43.02% | +281.46% | +258.18% | +579.96% | 20.81B | |
| +0.45% | +2.06% | +1.65% | +17.90% | +10.82% | +14.33% | +171.51% | +230.99% | +1,913.68% | 17.3B | |
| -1.70% | -0.86% | -2.12% | -1.70% | +172.60% | +149.75% | +358.65% | +1,398.21% | +710.15% | 14.99B | |
| +2.73% | +8.20% | +10.33% | +15.96% | +46.91% | +86.42% | +205.02% | +197.55% | +448.47% | 15.53B | |
| +0.08% | +0.69% | +3.35% | +11.11% | +26.60% | +23.63% | +71.78% | -29.45% | +86.81% | 15.37B | |
| +1.90% | +4.98% | -1.01% | -6.92% | - | - | - | - | - | 15.1B | |
| +5.14% | +5.49% | +13.45% | +43.58% | +58.14% | +71.31% | +70.14% | -25.15% | +280.06% | 14.32B | |
| +3.54% | +4.00% | +1.39% | -7.14% | +19.33% | -2.34% | +545.07% | - | - | 13.77B | |
| +3.60% | +5.99% | +6.14% | +4.82% | -4.41% | -7.57% | -23.17% | -36.96% | +105.58% | 12.97B | |
| Average | +2.44% | +1.91% | +2.20% | +13.11% | +36.83% | +41.35% | +154.98% | +159.11% | +863.71% | 26.92B | |
| Weighted average by Cap. | +2.65% | +2.01% | +1.62% | +14.56% | +37.57% | +43.42% | +140.98% | +126.39% | +1,163.18% |
- Stock Market
- Stocks
- Stock
- Sector Pharmacyclics, Inc.
Select your edition
All financial news and data tailored to specific country editions
